CombiGene AB Developing CG01 Gene Therapy for Epilepsy Treatment
Accelero is proud becoming a selected partner for the leading Nordic gene therapy company CombiGene AB (Lund) developing an AAV-based treatment targeting epilepsy.
Blog
Berlin Cures GmbH Publishes Promising Phase 1 Data Results
Berlin Cures GmbH is a clinical stage pharmaceutical company developing a short DNA aptamer BC 007 for the treatment of pathogenic autoantibodies against G-protein coupled receptors.
Health Authority Contracted Accelero for SARS-CoV-2 Testing
One of Berlin´s health authorities (Gesundheitsamt Treptow-Köpenick) has signed a contract for Accelero´s SARS-CoV-2 RT-PCR testing capabilities. The Berlin Senate Administration for Health asked Accelero to purchase swaps in bulk.
FDA Approved Nabriva Therapeutics Lefamulin for both Oral and IV Use
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.
Accelero Exhibitor @ Nordic Life Science Days 2019
The Nordic Life Science Days event is well known as the largest biotech conference in Scandinavia. This year the event was organized in Malmö/København on 10-12 September 2019. Accelero for the first time participated as an exhibitor - and drew attention with it´s own booth.
Bioanalysis of Human MSC Biodistribution Published
Accelero´s GLP compliant bioanalytical services have recently been published in Cytotherapy 21 (2019): 546-560.
Awesome ACCELERO Hoodie Out Now! Limited Edition!
Get the brand new ACCELERO hoodie - the first product from our emerging new accessory collection!
This product is part of a limited edition and is only available for a short time.
If you are client of our GLP test facility, get your own hoodie for free!
Accelero as Startup Expert Mentor @ BioVaria 2019
The BioVaria 2019 event is one of Germany´s leading showcasing events for commercially attractive licencing opportunities and innovative startups from across Europe. The event has been organized by Ascenion GmbH, one of Germany´s leading technology transfer agencies, at the Sofitel Munich Bayerpost Hotel from 08-09 May 2019.
Guiding ATMPs to Patients - CAMP SweLife Meeting in Mölndal
Accelero will participate in the 2nd National ATMP Conference organized by the Center for Advanced Medical Products (CAMP) funded by VINNOVA, the Swedish Governmental Agency for Innovation Systems). The event will take place at the AstraZeneca campus south of Göteborg on Thursday 04-APR-2019.
German Quality Management Association - Annual Congress in Berlin
Accelero feels constrained to assure highest quality for our regulatory studies. Team members will participate in the following annual congresses of quality assurance associations: 24. Annual Congress of the German Quality Management Association - 27 March 2019 Berlin 35. Annual Congress of the German Society for Pharmaceutical Medicine - 28 March 2019 Berlin.
CGT Catapult - Charité Scientific Meeting on Advanced Therapies
Accelero is invited to participate in the Scientific Meeting "British German Alliance for Advanced Therapies" taking place in the British Embassy in Berlin on 26 March 2019.
First English GLP Seminar @ Client´s Site in Europe
The test facility manager was invited to hold a GLP round table seminar at one of Accelero´s clients based in Europe about the organization and management of (international) multi-site studies in compliance to GLP.
Importing Non-Human Primate Samples into the European Union
A brief anecdote about the inconvenient import procedure for non-human primate specimen collected from non-European origins and covered by CITES regulations.
GLP Seminars 2019: Registration is now open
The company is pleased to open the registration for new Good Laboratory Practice (GLP) seminars in 2019: Basic courses as well as a summer seminar on computerized systems are available!
Renewal of GLP Compliance Confirmed by Authority for Another 3 Years
Accelero is proud to announce that the test facility successfully passed a GLP inspection conducted on 15th and 16th of November 2018 by the competent state authority in Berlin, Germany.
Approval to Process Samples of Biosafety Level 3(**)
Accelero is now allowed to process potentially infectious biological agents of risk group 3, which are normally not transmitted by air.
Annual Meeting of the German Quality Management Association (GQMA)
Meet Accelero team members at the 23rd International Meeting of the German Quality Management Association on 20-21 September 2018 in Bonn, Germany.
Accelero Exhibitor @BIONNALE 2018
The company presented at the BIONNALE 2018 in Berlin - the largest biotech event in Germany´s capital region!
Just Hatched: Accelero MultiPlex Immunoassay Services
Accelero extends multiplex immunoassay capabilities - Luminex - LEGENDplex - FirePlex !
Accelero Participates in Veterinary Pharmacology Project
After eight years of serving the biotechnology business with bioanalytical services on human therapeutics, Accelero now is very pleased to support the regulatory development of an ATMP for veterinary pharmacology.
Contact
Office and Management:
Accelerō® Bioanalytics GmbH
Schulzestrasse 20
13187 Berlin
GERMANY
| +49 30 610 910 300 (Office) | |
| service(at)accelero-bioanalytics.com |